Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Wing K Liu"'
Autor:
Wing K Liu, Alison Tree, Reena Patel, Nick Watkin, Benjamin Ayres, Mehran Afshar, Lisa Pickering, Louise English
Publikováno v:
International Urology and Nephrology
Purpose Red cell distribution width (RDW) measures red cells’ size variability. Metastatic penile cancer displays poor chemotherapy response. As no validated prognostic predictor exists, we investigated whether RDW correlates independently with sur
Autor:
Bernadett Szabados, Francesca Jackson-Spence, Thomas Powles, T. Butters, Wing K. Liu, Axel Bex, M. Grant, J. M. Lam
Publikováno v:
World Journal of Urology. 38:3199-3205
Metastatic renal cell carcinoma (mRCC) represents a significant and rising burden of disease, with rapidly evolving treatment modalities. The role of cytoreductive nephrectomy (CN) is controversial in this setting. As such, London Cancer has pursued
Autor:
Wing K Liu, Thomas Butters, Alfred So, Mehran Ashfar, James Lam, Francesca Jackson-Spence, Ghufoor Zaynub, M. Grant, Bernadett Szabados, Deborah Enting, Thomas Powles
Publikováno v:
International Journal of Cancer Management. 14
Background: Cancer types eligible for treatment with immune checkpoint inhibitors (ICI) have increased over the past decade thus simultaneously growing the number of patients presenting to emergency departments (ED) with immune mediated toxicities. O
Publikováno v:
Melanoma research. 31(1)
Single-agent anti-PD1 antibodies are usually very well tolerated, but serious toxicity can still occur. Despite the PD-1 pathway seems to be relevant in the pathogenesis of immune-related myositis, anti-PD1-related myositis is generally a rare side e
Autor:
Wing K, Liu, J M, Lam, T, Butters, M, Grant, F, Jackson-Spence, A, Bex, T, Powles, B, Szabados
Publikováno v:
World journal of urology. 38(12)
Metastatic renal cell carcinoma (mRCC) represents a significant and rising burden of disease, with rapidly evolving treatment modalities. The role of cytoreductive nephrectomy (CN) is controversial in this setting. As such, London Cancer has pursued
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology
The two recent prospective randomized trials CARMENA and SURTIME have changed the therapy paradigm of metastatic renal cell carcinoma. The CARMENA trial was conducted to investigate whether cytoreductive nephrectomy (CN) is required in the targeted t
Publikováno v:
European urology oncology. 4(4)
There are few data on outcomes for patients with metastatic urothelial carcinoma (MUC) who receive chemotherapy (CT) after progression on immune checkpoint inhibitors (ICIs). We carried out a retrospective single-centre analysis of MUC patients who p
Autor:
Reena Patel, Hiten Rh Patel, Ruairidh Crawford, Mehran Ashfar, Alison Tree, Benjamin Ayres, Nick Watkin, Wing K Liu, Lisa Pickering
Publikováno v:
Journal of Clinical Urology. :205141582110259
Objective: This study aimed to provide real-world data on the multidisciplinary management of metastatic penile squamous-cell carcinoma (mpSCC) patients and their survival outcomes, particularly those who receive best supportive care (BSC). Methods:
Autor:
Srinivas Abbina, Amr S. Abu Lila, Mohsen Adeli, Resmi Anand, Rajendra Awasthi, Sahar Awwad, Ali Bodaghi, Steve Brocchini, Abbas Dadkhah, Poppy Das, Bekir Dizman, Kamal Dua, Zhihao Fang, Alessandro Fisher, Mónica C. García, Homa Gheybi, Claire Ginn, Gaurav Gupta, Narges Hadjesfandiari, Tatsuhiro Ishida, Amalin Kavitha, Mthulisi Khuphe, Ying Li, Wing K. Liu, Himaja Malipeddi, Satish Manchanda, Kavita Pabreja, Anilkumar Parambath, Terezinha D.J.A. Pinto, Shabnam Sattari, Zhiqiang Shen, Rajesh A. Shenoi, Taro Shimizu, Meenakshi Singh, Khadijeh Soleimani, Nazia Tarannum, Paul D. Thornton, Jijo Vallooran, Vinodhini Velu, Tacey X. Viegas, Rebecca Weimer, Kunsang Yoon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b90c57f9ba632e43df590acca67f18c
https://doi.org/10.1016/b978-0-08-101750-0.00020-9
https://doi.org/10.1016/b978-0-08-101750-0.00020-9
Publikováno v:
European Urology Supplements. 18:e3520-e3521